Related Experiment Video
Updated: Mar 20, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
1.1K
Ethnic Considerations for Metabolic Surgery
1Section of Bariatric and Minimally Invasive Surgery, Stanford University School of Medicine, Stanford, CA morton@stanford.edu.
Diabetes Care
|May 26, 2016
Summary
Metabolic surgery effectively treats obesity and diabetes, with outcomes like diabetes remission showing no ethnic disparities. However, weight loss and complication rates may vary across different ethnic groups.
Area of Science:
- Endocrinology
- Bariatric Surgery
- Public Health
Background:
- Obesity and type 2 diabetes are significant global health challenges.
- Metabolic surgery is a proven treatment for both conditions.
- Ethnic variations in disease prevalence suggest potential differences in surgical outcomes.
Purpose of the Study:
- To investigate ethnic variations in indications and outcomes of metabolic surgery.
- To examine factors influencing metabolic surgery results across diverse ethnic groups.
Main Methods:
- Review of existing literature on metabolic surgery outcomes stratified by ethnicity.
- Analysis of weight loss, complication rates, and comorbidity remission.
- Exploration of influencing factors: access, biology, culture, genetics, procedure, and socioeconomic status.
Main Results:
- Evidence suggests ethnic variations in weight loss and complication rates after metabolic surgery.
- Diabetes remission appears consistent across different ethnic groups.
- Multiple factors including access, biology, culture, genetics, procedure, and socioeconomic status impact outcomes.
Conclusions:
- While metabolic surgery is effective for obesity and diabetes, ethnic disparities may exist in specific outcomes.
- Diabetes remission is a promising area free from ethnic variation.
- Further research is needed to fully understand and refine the role of ethnicity in metabolic surgery outcomes.
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
272
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
272
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
360
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
360
01:26Kidney Transplant II: Surgical Procedure
733
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
733
01:28Kidney Transplant I: Introduction
670
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
670
01:20Inborn Errors of Metabolism
995
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995